ewsba.se
Is NHC a good stock to buy? We came across a bearish thesis on National HealthCare Corporation on Valueinvestorsclub.com by FLATtheFISH. In this article, we will summarize the bears’ thesis on NHC. National HealthCare Corporation's share was trading at $176.38 as of April 27th. NHC’s trailing P/E was 23.00 according to Yahoo Finance.
NHC is a diversified post-acute care operator spanning skilled nursing facilities (SNFs), assisted living, hospice, and home health services, positioned at a ~$1.95B market cap with a highly exposed lease-driven economic structure. The investment case is decisively bearish as decades of below-market rent agreements with National Health Investors (NHI), sustained through overlapping governance and insider relationships, begin to unwind into a 2026 rent reset that threatens to reprice roughly half of NHC’s facilities toward fair market levels, implying material EBITDA compression and potential revenue disruption if lease negotiations deteriorate further.
Recent governance shifts, including activist pressure at NHI, issuance of default notices, and the removal of long-standing NHC-linked directors, signal escalating friction and reduce the likelihood of favorable lease renewal terms, raising the probability of adverse restructuring or third-party re-leasing of assets. Operationally, NHC faces deteriorating fundamentals, with CMS data indicating weak quality scores, high nurse turnover, inspection gaps, and potential compliance violations that could force meaningful wage inflation and regulatory scrutiny, increasing annual costs by tens of millions.
Simultaneously, structural reimbursement pressure from Medicare Advantage adoption and a broader pivot toward home health is compressing skilled nursing volumes and margins, undermining NHC’s traditional patient mix advantage. Combined, these factors suggest a ~58% downside to intrinsic value under normalized rent, labor, and payer assumptions, while limited sell-side coverage and opaque disclosures exacerbate mispricing risk.
Catalysts over 2025–2026 include default litigation developments, board restructuring, and lease renegotiation disclosures, each likely accelerating downside realization into a prolonged valuation reset phase ahead.
Previously, we covered a bullish thesis on Tenet Healthcare Corporation (THC) by BlackSwanInvestor in December 2024, which highlighted ambulatory care-driven margin expansion, deleveraging, and strong cash flow growth. THC’s stock price has appreciated by approximately 47.59% since our coverage. FLATtheFISH shares a contrarian view but emphasizes NHC’s lease reset risk, governance deterioration, and reimbursement pressure, reflecting a structurally weaker post-acute care outlook.
National HealthCare Corporation is not on our list of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 16 hedge fund portfolios held NHC at the end of the fourth quarter which was 14 in the previous quarter. While we acknowledge the risk and potential of NHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than NHC and that has 10,000% upside potential, check out our report about this cheapest AI stock.